https://www.selleckchem.com/pr....oducts/golvatinib-e7
Mean forced vital capacity and forced expiratory volume in 1s were 0.87L and 0.78L, respectively at baseline and 1.05L and 0.88L after a mean follow-up of 5.5years. PRO data showed overall improvements over time in Mobility, Self-care, and Caregiver assistance scores of the MPS-Health Assessment Questionnaire, relatively stable quality of life, and some improvements in pain scores. The MAA data confirm the effects of elosulfase alfa on clinical and PRO results observed in the clinical trials and provide real-world evidence for
Like
Comment
Share
